ZA90776B - Modified release gemfibrozil composition - Google Patents

Modified release gemfibrozil composition

Info

Publication number
ZA90776B
ZA90776B ZA90776A ZA90776A ZA90776B ZA 90776 B ZA90776 B ZA 90776B ZA 90776 A ZA90776 A ZA 90776A ZA 90776 A ZA90776 A ZA 90776A ZA 90776 B ZA90776 B ZA 90776B
Authority
ZA
South Africa
Prior art keywords
granulation
pharmaceutically acceptable
gemfibrozil
finely divided
divided particles
Prior art date
Application number
ZA90776A
Other languages
English (en)
Inventor
Isaac Ghebre-Sellassie
Ghebre-Sellassie Isaac
Robert Harry Gordon
Harry Gordon Robert
Sadath U Khan
U Khan Sadath
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA90776B publication Critical patent/ZA90776B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA90776A 1989-02-02 1990-02-01 Modified release gemfibrozil composition ZA90776B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/305,082 US4927639A (en) 1989-02-02 1989-02-02 Modified release gemfibrozil composition

Publications (1)

Publication Number Publication Date
ZA90776B true ZA90776B (en) 1991-10-30

Family

ID=23179253

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90776A ZA90776B (en) 1989-02-02 1990-02-01 Modified release gemfibrozil composition

Country Status (21)

Country Link
US (1) US4927639A (fr)
EP (1) EP0381219B1 (fr)
JP (1) JPH02240017A (fr)
KR (1) KR0137268B1 (fr)
CN (1) CN1053744A (fr)
AT (1) ATE88889T1 (fr)
AU (1) AU622751B2 (fr)
CA (1) CA2009135A1 (fr)
DE (1) DE69001488T2 (fr)
DK (1) DK0381219T3 (fr)
ES (1) ES2055177T3 (fr)
FI (1) FI900491A7 (fr)
HU (1) HU204192B (fr)
IE (1) IE900371L (fr)
IL (1) IL92994A (fr)
MY (1) MY104898A (fr)
NO (1) NO900484L (fr)
NZ (1) NZ232321A (fr)
PH (1) PH26317A (fr)
PT (1) PT93029A (fr)
ZA (1) ZA90776B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5331756A (en) * 1988-05-04 1994-07-26 Rehrig International, Inc. Basket wall with placard display assembly
EP0462067A1 (fr) * 1990-06-15 1991-12-18 Warner-Lambert Company Formulations de gemfibrozil
EP0462066A1 (fr) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil amorphe
EP0475894A1 (fr) * 1990-08-27 1992-03-18 Warner-Lambert Company Formulations améliorées de gemfibozile
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
US5358723A (en) * 1991-11-26 1994-10-25 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
JPH07503236A (ja) * 1991-11-26 1995-04-06 ワーナー−ランバート・コンパニー 制御放出性ジェムフィブロジル剤形の開発のための方法および組成物
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
EP1690531A3 (fr) * 1996-09-30 2010-01-20 Alza Corporation Forme de dosage et méthode d'administration de médicament
CA2264852C (fr) * 1996-09-30 2005-11-01 Alza Corporation Utilisation de methylphenidate ou d'un sel pharmaceutique acceptable correspondant
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6838091B2 (en) * 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
TW200404544A (en) * 2002-06-17 2004-04-01 Kowa Co Controlled release pharmaceutical composition
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
WO2005123045A2 (fr) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Formulation a dosage pharmaceutique contenant une matrice a liberation controlee
FI125478B (fi) * 2010-03-30 2015-10-30 Pertti Neuvonen Farmaseuttinen koostumus, joka sisältää gemfibrotsiiliä ja CYP2C8- ja/tai OATP-substraattilääkettä
WO2016048826A1 (fr) * 2014-09-22 2016-03-31 Amphenol InterCon Systems, Inc. Ensemble interposeur et procédé
HUE067496T2 (hu) 2020-12-08 2024-10-28 Ruminant Biotech Corp Ltd Az állatoknak szánt anyagok bejuttatására szolgáló eszközök és módszerek fejlesztése

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US4291016A (en) * 1976-07-27 1981-09-22 Sandoz Ltd. Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
US4195084A (en) * 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
WO1988005296A2 (fr) * 1987-01-27 1988-07-28 Warner-Lambert Company Compositions regulatrices de lipides

Also Published As

Publication number Publication date
AU4899290A (en) 1990-08-09
DK0381219T3 (da) 1993-06-01
IE900371L (en) 1990-08-02
HUT52950A (en) 1990-09-28
NZ232321A (en) 1991-02-26
DE69001488D1 (de) 1993-06-09
NO900484L (no) 1990-08-03
FI900491A7 (fi) 1990-08-03
NO900484D0 (no) 1990-02-01
AU622751B2 (en) 1992-04-16
IL92994A0 (en) 1990-09-17
PT93029A (pt) 1990-08-31
US4927639A (en) 1990-05-22
MY104898A (en) 1994-06-30
HU204192B (en) 1991-12-30
CA2009135A1 (fr) 1990-08-02
PH26317A (en) 1992-04-29
DE69001488T2 (de) 1993-08-26
EP0381219A3 (en) 1990-12-05
JPH02240017A (ja) 1990-09-25
FI900491A0 (fi) 1990-01-31
HU900638D0 (en) 1990-04-28
CN1053744A (zh) 1991-08-14
IL92994A (en) 1994-04-12
ES2055177T3 (es) 1994-08-16
EP0381219B1 (fr) 1993-05-05
KR0137268B1 (ko) 1998-04-25
EP0381219A2 (fr) 1990-08-08
KR900012604A (ko) 1990-09-01
ATE88889T1 (de) 1993-05-15

Similar Documents

Publication Publication Date Title
ZA90776B (en) Modified release gemfibrozil composition
EP0157695B1 (fr) Formes de dose solides d'un médicament à libération contrôlée à base de mélanges d'éthers cellulosiques hydrosolubles et de tensioactifs anioniques
EP0322222B1 (fr) Formes d'administration de médicaments à effet prolongé à base d'hydroxypropylméthylcellulose et de sels de métaux alcalins d'acides carboxyliques
US4540566A (en) Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
US3773920A (en) Sustained release medicinal composition
CA1188614A (fr) Compose therapeutique a liberation continue basee sur le poids moleculaire eleve de l'hydroxypropylmethycellulose
US4849229A (en) Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
EP0108218A2 (fr) Forme de dosage orale solide à libération constante de composés pharmaceutiques très solubles dans l'eau
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
NZ228122A (en) Pharmaceutical granulate containing cellulose substance and wet-binding agent; dosage form and process for preparation
NZ336789A (en) Use of methacrylic acid copolymer type C in the manufacture of tablets
AU7992987A (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch
KR880012213A (ko) 이부프로펜 서방형 매트릭스 및 이의 제조방법
KR880010757A (ko) 제약정제, 제약과립 및 그의 제조방법
MY104010A (en) Pharmaceutical compositions.
CA2045680A1 (fr) Granules ayant une forte teneur en ibuprofene
ES8801121A1 (es) Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.
EP0297866A3 (fr) Agents thérapeutiques
GEP20033078B (en) Controlled-Release Compositions of Betahistine
CA2361496A1 (fr) Preparations pharmaceutiques a liberation prolongee independante du ph
JPS5781409A (en) External plaster
Bansal et al. Effect of formulation and process variables on the dissolution profile of naproxen sodium from tablets
AU609234B2 (en) Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
JPS5344617A (en) Drug composition
HU215191B (hu) Eljárás Levodopa és Carbidopa hatóanyag-kombinációt tartalmazó, szabályozott hatóanyag-leadású, központi dopaminhiányos állapotok kezeléséhez alkalmas orális gyógyszerkészítmény előállítására